ABL Space Systems
Develops low-cost launch vehicles for the small satellite industry.
Achronix Semiconductor Corporation
Supplier of embedded field programmable gate array (eFPGA) technology.
Acquired by Allergan. Focused on the development of a small molecule therapy for the treatment of NASH.
High performance 4G & 5G coverage designed specifically for enterprise.
Manufactures public safety Digital Distributed Antenna Systems for Emergency Responder Radio Communications Systems.
Acquired by Amgen. Focused on the development of an oncolytic vaccine for melanoma and head and neck cancer.
Supplier of thin and flexible power solutions.
Focused on the development of tools for epigenetic analysis.
Focused on changing the economics of content storage and managing data through software designed object storage.
Acquired by Cephalon. Focused on the development of a biologic therapy for the treatment of asthma.
Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.
Dali Wireless, Inc.
Creator of a platform to provide mobile data service coverage that is scalable to the growth of mobile data demand.
Acquired by Amgen. Focused on the development of a small molecule therapy for dyslipidemia.
Utilizes diamond crystals to enable secure identification of physical objects.
Focused on the development of small molecule therapies for psoriasis.
Provider of high performance based storage software for real-time, big data, cloud, HPC, and other highly demanding data center applications.
Ferric Semiconductor, Inc.
Focused on creating single chip switching voltage regulators that are small, fast and efficient.
Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.
Fuzzy Logix, Inc.
Big data business analytics company focused on in-database analytics.
Developer of a proprietary publishing platform that offers a comprehensive digital, web, and mobile publishing solution.
Provider of cancer detection and radiation therapy solutions.
Provider of an automated solution for pharmacy pill-dispensing.
Focused on developing an organic photodetector material (OPD) for several commercial applications.
Focused on the development of a non-viral gene therapy for advanced peripheral artery disease.
Acquired by Welsh, Carson, Anderson & Stowe. Developer of solutions for the treatment of complex spinal pathologies.
Supplier of an innovative inkjet-based printing solution to enable printing of large-format organic light-emitting diodes (OLEDs) on a mass-production basis.
Acquired by Cisco. Developer of advanced optical interconnect technology for high-speed networking applications.
Focused on the commercialization of spectacles with digital lens technology.
Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.
Focused on the development of therapies for hard and soft tissue reconstruction from autologous adipose stem cells.
Ovizio Imaging Systems
Provider of digital holographic microscopy technology.
Focused on the development of next-generation enzyme replacement therapies for lysosomal storage diseases based on a yeast-based platform.
Global leader in advanced silicon-based power semiconductors
Acquired by Exact Sciences. Provider of a molecular diagnostic test to guide clinical decision making for cancer patients.
Global leader of graphene-based electronics technologies and products
Creator of the radio-frequency thruster for satellite propulsion.
Focused on generating higher quality atmospheric data through the design of a new satellite-deployed instrument.
Focused on the development of molecular assessments to improve the management of chronic diseases, with an initial focus on COPD.
Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.
Acquired by Agilent Technologies. Developer of tools for measuring cell metabolism.
Acquired by Audience. Developer of algorithms and software enabling consumer applications to better understand user contexts and intent.
Svelte Medical Systems
Developer of a radial drug-eluting stent platform to simplify cardiovascular stenting procedures.
Acquired by Zoll Medical. Developer of SuperSaturated Oxygen (SSO2) therapy to complement percutaneous coronary intervention.
Provider of a texting solution that is easy to use, flexible, easy to learn, and HIPAA (Health Insurance Portability and Accountability Act of 1996) compliant.
Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.
Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.
Acquired by CyberArk. Provider of encryption-in-use technology which enables businesses to encrypt their data before it goes to the cloud.
Building a world-class immunology company.
Vorago Technologies, Inc.
Provider of a patent-protected, process-based approach to harden semiconductor devices against radiation and thermal damage.
VUV Analytics, Inc.
Analytical instrumentation company focused on exploiting the vacuum UV band of the spectrum.
Developer of a platform to allow telco operators to monetize their data securely and at scale.